8-KOther Events

ABBOTT LABORATORIES 8-K Report (Jul 9, 2004)

Filed July 9, 2004For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on July 9, 2004, to announce its second quarter 2004 results of operations. The filing primarily directs investors to a press release (Exhibit 99.1) for detailed financial information. This press release likely contains key performance metrics and commentary from management regarding the company's performance during the quarter. Notably, the 8-K highlights Abbott's use of non-GAAP financial measures, such as "diluted earnings per common share from continuing operations excluding one-time charges." The company states that these adjusted measures are used internally and provided to investors to offer a clearer view of ongoing business performance by excluding unusual or unpredictable items. Investors are advised to consider these non-GAAP figures alongside, not as a replacement for, GAAP-based financial information.

Key Highlights

  • 1Abbott Laboratories announced its second quarter 2004 results of operations on July 9, 2004.
  • 2The primary disclosure mechanism for these results is a press release (Exhibit 99.1) furnished with the 8-K.
  • 3The filing explicitly mentions the use of non-GAAP financial measures by Abbott.
  • 4Key non-GAAP measures cited include diluted earnings per common share and earnings from continuing operations, excluding one-time charges.
  • 5Abbott's management believes these non-GAAP measures provide valuable insights into ongoing business performance.
  • 6The company cautions investors to view non-GAAP measures as supplemental to, and not substitutes for, GAAP-based financial statements.
  • 7Thomas C. Freyman, Executive Vice President, Finance and Chief Financial Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce Abbott Laboratories' financial results for the second quarter of 2004. The detailed results are provided in an accompanying press release.

Non-GAAP financial measures are financial metrics that exclude certain items from GAAP (Generally Accepted Accounting Principles) financial statements. Abbott is using them, such as earnings excluding one-time charges, to provide investors with a view of its ongoing business performance, free from unusual or unpredictable factors. Management also uses these internally to assess performance.

Investors should interpret these non-GAAP measures as supplementary information to help evaluate Abbott's ongoing operational performance. However, they should always consider these alongside the company's official financial results prepared in accordance with GAAP, as non-GAAP measures are not a substitute for GAAP reporting.

The detailed financial results are presented in the press release dated July 9, 2004, which is furnished as Exhibit 99.1 to this 8-K filing.